Literature DB >> 1379062

Specific detection of c-erbB-2 mRNA expression in gastric cancers by the polymerase chain reaction following reverse transcription.

I Ninomiya1, Y Endo, Y Yonemura, M Noguchi, S Fushida, M Nakai, H Takamura, F Harada, T Suzuki, I Miyazaki.   

Abstract

The expression of the c-erbB-2 mRNA in human embryonic lung fibroblasts, a gastric cancer cell line, mature placenta, and 25 gastric cancer tissues was examined by using the polymerase chain reaction following reverse transcription. This technique can be used to examine c-erbB-2 mRNA expression in a small endoscopic biopsy specimen before surgery.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1379062      PMCID： PMC1977918          DOI： 10.1038/bjc.1992.221

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  17 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.

Authors:  Y Yonemura; I Ninomiya; A Yamaguchi; S Fushida; H Kimura; S Ohoyama; I Miyazaki; Y Endou; M Tanaka; T Sasaki
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

3.  Molecular cloning and expression of an additional epidermal growth factor receptor-related gene.

Authors:  G D Plowman; G S Whitney; M G Neubauer; J M Green; V L McDonald; G J Todaro; M Shoyab
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

4.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

5.  Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.

Authors:  M S Berger; G W Locher; S Saurer; W J Gullick; M D Waterfield; B Groner; N E Hynes
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

6.  Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

Authors:  C R King; M H Kraus; S A Aaronson
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

7.  A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.

Authors:  K Semba; N Kamata; K Toyoshima; T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

8.  Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.

Authors:  L Coussens; T L Yang-Feng; Y C Liao; E Chen; A Gray; J McGrath; P H Seeburg; T A Libermann; J Schlessinger; U Francke
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

9.  Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.

Authors:  M H Kraus; W Issing; T Miki; N C Popescu; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.

Authors:  J Yokota; T Yamamoto; K Toyoshima; M Terada; T Sugimura; H Battifora; M J Cline
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321
View more
  3 in total

1.  Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations.

Authors:  J F Fléjou; F Paraf; F Muzeau; F Fékété; D Hénin; S Jothy; F Potet
Journal:  J Clin Pathol       Date:  1994-01       Impact factor: 3.411

2.  Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.

Authors:  Y Hirono; S Fushida; Y Yonemura; H Yamamoto; H Watanabe; A Raz
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

3.  Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer.

Authors:  F Miyazono; R Metzger; U Warnecke-Eberz; S E Baldus; J Brabender; E Bollschweiler; W Doerfler; R P Mueller; H P Dienes; T Aikou; A H Hoelscher; P M Schneider
Journal:  Br J Cancer       Date:  2004-08-16       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.